Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus

ABALI, SAYGIN; DEMİRCİOĞLU, SERAP; Atay, Zeynep; GÜRAN, TÜLAY; HALİLOĞLU, BELMA; BEREKET, ABDULLAH

doi:10.1111/pedi.12167

Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus

ABALI S., DEMİRCİOĞLU S., Atay Z., GÜRAN T., HALİLOĞLU B., BEREKET A.

PEDIATRIC DIABETES, cilt.16, sa.5, ss.361-366, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 5
Basım Tarihi: 2015
Doi Numarası: 10.1111/pedi.12167
Dergi Adı: PEDIATRIC DIABETES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.361-366
Anahtar Kelimeler: children, detemir, glargine, HbA1c, T1D, TREAT-TO-TARGET, PHARMACOKINETIC PROPERTIES, ANALOGS DETEMIR, STEADY-STATE, DOUBLE-BLIND, NPH INSULIN, LONG, ADOLESCENTS, VARIABILITY, PROFILE
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

ObjectiveWe aimed to compare hemoglobin A1c (HbA1c), total and basal insulin doses, basal insulin injection frequencies, and body mass index (BMI) in children with type 1 diabetes mellitus (T1DM) who are receiving detemir and glargine as basal insulin in a basal-bolus therapy.